These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15207481)

  • 1. Optimizing within-host viral fitness: infected cell lifespan and virion production rate.
    Gilchrist MA; Coombs D; Perelson AS
    J Theor Biol; 2004 Jul; 229(2):281-8. PubMed ID: 15207481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal viral production.
    Coombs D; Gilchrist MA; Percus J; Perelson AS
    Bull Math Biol; 2003 Nov; 65(6):1003-23. PubMed ID: 14607286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the importance of within- and between-host selection pressures on the evolution of chronic pathogens.
    Coombs D; Gilchrist MA; Ball CL
    Theor Popul Biol; 2007 Dec; 72(4):576-91. PubMed ID: 17900643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficient human immunodeficiency virus replication in mobile lymphocytes.
    Sourisseau M; Sol-Foulon N; Porrot F; Blanchet F; Schwartz O
    J Virol; 2007 Jan; 81(2):1000-12. PubMed ID: 17079292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
    Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
    Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication.
    Sakuragi J; Sakuragi S; Shioda T
    J Virol; 2007 Aug; 81(15):7985-92. PubMed ID: 17507464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV controllers: a homogeneous group of HIV-1 infected patients with a spontaneous control of viral replication].
    Lambotte O; Delfraissy JF
    Pathol Biol (Paris); 2006 Dec; 54(10):566-71. PubMed ID: 17027185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo estimates of natural variation in HIV infection.
    Heffernan JM; Wahl LM
    J Theor Biol; 2005 Sep; 236(2):137-53. PubMed ID: 16005307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.
    Gali Y; Berkhout B; Vanham G; Bakker M; Back NK; Ariën KK
    Virology; 2007 Jul; 364(1):140-6. PubMed ID: 17395236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral reproductive strategies: How can lytic viruses be evolutionarily competitive?
    Komarova NL
    J Theor Biol; 2007 Dec; 249(4):766-84. PubMed ID: 17945261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analysis of a nonlinear lumped parameter model of HIV infection dynamics.
    Bortz DM; Nelson PW
    Bull Math Biol; 2004 Sep; 66(5):1009-26. PubMed ID: 15294416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference and HIV-1 infection.
    Kanzaki LI; Ornelas SS; Argañaraz ER
    Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and host factors in the pathogenesis of HIV infection.
    Derdeyn CA; Silvestri G
    Curr Opin Immunol; 2005 Aug; 17(4):366-73. PubMed ID: 15955686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4/CXCR4 co-expression allows productive HIV-1 infection in canine kidney MDCK cells.
    Cervantes-Acosta G; Welman M; Freund F; Cohen EA; Lemay G
    Virus Res; 2006 Sep; 120(1-2):138-45. PubMed ID: 16600413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death.
    Funk GA; Oxenius A; Fischer M; Opravil M; Joos B; Flepp M; Weber R; Günthard HF; Bonhoeffer S
    J Med Virol; 2006 Sep; 78(9):1141-6. PubMed ID: 16847964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The host environment drives HIV-1 fitness.
    van Opijnen T; Berkhout B
    Rev Med Virol; 2005; 15(4):219-33. PubMed ID: 15942979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.